Left Atrial Volume Index: A Predictor of Adverse Outcome in Patients With Hypertrophic Cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 22, Issue 12, 2009, Pages 1338-1343

  Yang, Woo In ^a   Shim, Chi Young ^a   Kim, Young Jin ^a   Kim, Sung Ai ^a   Rhee, Sang Jae ^a   Choi, Eui Young ^a   Choi, Donghoon ^a   Jang, Yangsoo ^a   Chung, Namsik ^a   Cho, Seung Yun ^a   Ha, Jong Won ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIAC MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DEATH; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; STROKE; SUDDEN DEATH; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; KOREA; MALE; MIDDLE AGED; ORGAN SIZE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 70450228483     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2009.09.016     Document Type: Article

References (34)

1. Wigle E.D., Sasson Z., Henderson M.A., Ruddy T.D., Fulop J., Rakowski H., et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 28 (1985) 1-83
2. Nihoyannopoulos P., Karatasakis G., Frenneaux M., McKenna W.J., and Oakley C.M. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 19 (1992) 536-540
3. Beinart R., Boyko V., Schwammenthal E., Kuperstein R., Sagie A., Hod H., et al. Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol 44 (2004) 327-334
4. Tsang T.S., Barnes M.E., Gersh B.J., Takemoto Y., Rosales A.G., Bailey K.R., et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 42 (2003) 1199-1205
5. Rossi A., Cicoira M., Zanolla L., Sandrini R., Golia G., Zardini P., et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 1425
6. Nunes M.C., Barbosa M., Ribeiro A.L., Colosimo E.A., and Rocha M.O. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr 22 (2009) 82-88
7. Lombardi R., Betocchi S., Losi M.A., Tocchetti C.G., Aversa M., Miranda M., et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108 (2003) 1455-1460
8. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
9. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
10. Teraoka K. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 23 (2005) 701
11. Zoghbi W.A., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Levine R.A., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
12. Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
13. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
14. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
15. Maron B.J., Estes N.A., Maron M.S., Almquist A.K., Link M.S., and Udelson J.E. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 107 (2003) 2872-2875
16. Geisterfer-Lowrance A.A., Christe M., Conner D.A., Ingwall J.S., Schoen F.J., Seidman C.E., et al. A mouse model of familial hypertrophic cardiomyopathy. Science 272 (1996) 731-734
17. Nagueh S.F., Bachinski L.L., Meyer D., Hill R., Zoghbi W.A., Tam J.W., et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104 (2001) 128-130
18. Greenberg B., Chatterjee K., Parmley W.W., Werner J.A., and Holly A.N. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 98 (1979) 742-751
19. Pritchett A.M., Mahoney D.W., Jacobsen S.J., Rodeheffer R.J., Karon B.L., and Redfield M.M. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 45 (2005) 87-92
20. Kjaergaard J., Johnson B.D., Pellikka P.A., Cha S.S., Oh J.K., and Ommen S.R. Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 18 (2005) 1373-1380
21. Sachdev V., Shizukuda Y., Brenneman C.L., Birdsall C.W., Waclawiw M.A., Arai A.E., et al. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J 149 (2005) 730-736
22. Nistri S., Olivotto I., Betocchi S., Losi M.A., Valsecchi G., Pinamonti B., et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 98 (2006) 960-965
23. Tsang T.S., Abhayaratna W.P., Barnes M.E., Miyasaka Y., Gersh B.J., Bailey K.R., et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?. J Am Coll Cardiol 47 (2006) 1018-1023
24. Yang H., Woo A., Monakier D., Jamorski M., Fedwick K., Wigle E.D., et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 18 (2005) 1074-1082
25. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., and Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104 (2001) 2517-2524
26. Chiariello M., Barbati G., Tocchetti C., Cacace A., D'Alessandro G., Miranda M., et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 94 (2004) 895-900
27. Losi M.A., Betocchi S., Barbati G., Parisi V., Tocchetti C.G., Pastore F., et al. Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 22 (2009) 76-81
28. Rickers C., Wilke N.M., Jerosch-Herold M., Casey S.A., Panse P., Panse N., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
29. Choi D.S., Ha J.W., Choi B., Yang W.I., Choi E.Y., Rim S.J., et al. Extent of late gadolinium enhancement in cardiovascular magnetic resonance and its relation with left ventricular diastolic function in patients with hypertrophic cardiomyopathy. Circ J 72 (2008) 1449-1453
30. Elliott P.M., Gimeno Blanes J.R., Mahon N.G., Poloniecki J.D., and McKenna W.J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
31. Nakagawa H., Inaba Y., Kitabatake A., Morikawa Y., Soyama Y., Matsumori A., et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 93 (2007) 711-715
32. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
33. Maron B.J., Olivotto I., and Maron M.S. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?. Eur Heart J 27 (2006) 1895-1897
34. Biagini E., Coccolo F., Ferlito M., Perugini E., Rocchi G., Bacchi-Reggiani L., et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 46 (2005) 1543-1550